ah 13205 has been researched along with cyclohexanol in 1 studies
Studies (ah 13205) | Trials (ah 13205) | Recent Studies (post-2010) (ah 13205) | Studies (cyclohexanol) | Trials (cyclohexanol) | Recent Studies (post-2010) (cyclohexanol) |
---|---|---|---|---|---|
16 | 0 | 1 | 4,548 | 691 | 1,355 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boxberger, M; Choritz, L; Krauss, A; Meissner, S; Rosenthal, R; Stumpff, F; Thieme, H; Wiederholt, M | 1 |
1 other study(ies) available for ah 13205 and cyclohexanol
Article | Year |
---|---|
Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Adult; Aged; Animals; Benzoxazines; Calcium; Calcium Channel Blockers; Cannabinoids; Carbachol; Cattle; Cells, Cultured; Cholinergic Agonists; Cyclic AMP; Cyclohexanols; Endothelin-1; Humans; In Vitro Techniques; Ion Channel Gating; Middle Aged; Morpholines; Naphthalenes; Patch-Clamp Techniques; Peptides; Piperidines; Potassium Channels, Calcium-Activated; Prostanoic Acids; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Prostaglandin E; Stimulation, Chemical; Trabecular Meshwork | 2005 |